click tracking
Austrian Biotech Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 61 - 80 out of 108 displayed.
«  1  2  3 4  5  6 »

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: GlobenewsWire - 21 Jun 2021

European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

Read more ››
By: GlobenewsWire - 18 Jun 2021

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: GlobenewsWire - 14 Jun 2021

COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnson’s Emergency Use Authorization

Read more ››
By: GlobenewsWire - 11 Jun 2021
Related companies:  Emergent BioSolutions Inc. | Erste Group Bank AG

New pivotal data at EHA 2021 reinforces sutimlimab as a first-in-class investigational C1s inhibitor with the potential to be the first approved treatment for hemolysis in people with CAD, a serious and chronic autoimmune hemolytic anemia  

Read more ››
By: GlobenewsWire - 11 Jun 2021

Phosplatin Therapeutics to Present at 2021 BIO Digital

Read more ››
By: PR Newswire Association LLC. - 10 Jun 2021

Results from Qu Biologics’ Crohn’s Disease RESTORE Trial Selected for Oral Presentation at ECCO 2021

Read more ››
By: GlobenewsWire - 09 Jun 2021

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: GlobenewsWire - 07 Jun 2021

Sanofi launches its new global employee share ownership plan

Read more ››
By: GlobenewsWire - 07 Jun 2021

Wegovy™ (semaglutide 2.4 mg), the first and only once-weekly GLP-1 therapy for weight management, approved in the US

Read more ››
By: GlobenewsWire - 04 Jun 2021

Sanofi launches €3 million Planet Mobilization fund to support employees’ environmental projects

Read more ››
By: GlobenewsWire - 03 Jun 2021

Novo Nordisk resubmits once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes for US regulatory approval

Read more ››
By: GlobenewsWire - 28 May 2021

Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate

Read more ››
By: GlobenewsWire - 27 May 2021

AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of Clinical Pharmacology

Read more ››
By: GlobenewsWire - 27 May 2021
Related companies:  AFFiRiS AG

Emergent BioSolutions Announces Positive Two-Year Persistence Data From Phase 2 Study Evaluating CHIKV VLP, the Company’s Chikungunya Virus Virus-Like Particle Vaccine Candidate

Read more ››
By: GlobenewsWire - 26 May 2021
Related companies:  Emergent BioSolutions Inc. | Erste Group Bank AG

Lexogen gains ISO 9001:2015 quality management certification.

Read more ››
By: PR Newswire Association LLC. - 26 May 2021
Related companies:  Lexogen GmbH

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)

Read more ››
By: PR Newswire Association LLC. - 25 May 2021

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: GlobenewsWire - 25 May 2021

Boehringer Ingelheim's Investigational Treatment for Cognitive Impairment Associated with Schizophrenia Receives FDA Breakthrough Therapy Designation

BI 425809, A Novel Glycine transporter-1 (GlyT1) Inhibitor To Be Studied in First-of-its-Kind Phase III Trials, Incorporating Speech Analytics and Virtual Reality Functional Capacity Assessments Read more ››
By: PR Newswire Association LLC. - 24 May 2021

Sanofi to showcase data from its transformative oncology pipeline at 2021 ASCO Meeting

Read more ››
By: GlobenewsWire - 19 May 2021
«  1  2  3 4  5  6 »

Looking for companies outside of Austria?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • October 2021
    • BIO-Europe® 2021
    • Online: AusBiotech 2021 & Australia Biotech Invest & Partnering
  • November 2021
    • Pharma-Biotech Product & Company Valuation with Dr. P Frei
See Events »
Add an Event »

Latest company news

Emergent BioSolutions to Release Third Quarter 2021 Financial Results and Conduct a Conference Call on November 4, 2021
18 Oct 2021 (GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
18 Oct 2021 (GlobenewsWire)

Emergent BioSolutions Announces Initiation of Pivotal Phase 3 Study Evaluating the Safety and Immunogenicity of Its Single-Dose Chikungunya Vaccine Candidate, CHIKV VLP
15 Oct 2021 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Austrian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com